These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17540338)

  • 1. Cardiac-specific activation of Cre expression at late fetal development.
    Opherk JP; Yampolsky P; Hardt SE; Schoels W; Katus HA; Koenen M; Zehelein J
    Biochem Biophys Res Commun; 2007 Jul; 359(2):209-13. PubMed ID: 17540338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse.
    Hayashi S; McMahon AP
    Dev Biol; 2002 Apr; 244(2):305-18. PubMed ID: 11944939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Podocyte-specific expression of cre recombinase in transgenic mice.
    Moeller MJ; Sanden SK; Soofi A; Wiggins RC; Holzman LB
    Genesis; 2003 Jan; 35(1):39-42. PubMed ID: 12481297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo.
    Kisanuki YY; Hammer RE; Miyazaki J; Williams SC; Richardson JA; Yanagisawa M
    Dev Biol; 2001 Feb; 230(2):230-42. PubMed ID: 11161575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MyoD-cre transgenic mice: a model for conditional mutagenesis and lineage tracing of skeletal muscle.
    Chen JC; Mortimer J; Marley J; Goldhamer DJ
    Genesis; 2005 Mar; 41(3):116-21. PubMed ID: 15729689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell type-specific conditional regulation of the c-myc proto-oncogene by combining Cre/loxP recombination and tamoxifen-mediated activation.
    Jäger R; Maurer J; Jacob A; Schorle H
    Genesis; 2004 Mar; 38(3):145-50. PubMed ID: 15048812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic mice that express Cre recombinase under control of a skeletal muscle-specific promoter from mef2c.
    Heidt AB; Black BL
    Genesis; 2005 May; 42(1):28-32. PubMed ID: 15828002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the fate of Sry-expressing cells using an in vivo Cre/loxP system.
    Ito M; Yokouchi K; Yoshida K; Kano K; Naito K; Miyazaki J; Tojo H
    Dev Growth Differ; 2006 Jan; 48(1):41-7. PubMed ID: 16466392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2.
    Hirrlinger PG; Scheller A; Braun C; Hirrlinger J; Kirchhoff F
    Glia; 2006 Jul; 54(1):11-20. PubMed ID: 16575885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal regulation of Cre-recombinase activity in Scl-positive neurons of the central nervous system.
    Bradley CK; Takano EA; Göthert JR; Göttgens B; Green AR; Begley CG; van Eekelen JA
    Genesis; 2007 Mar; 45(3):145-51. PubMed ID: 17330263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting of cre to the Foxg1 (BF-1) locus mediates loxP recombination in the telencephalon and other developing head structures.
    Hébert JM; McConnell SK
    Dev Biol; 2000 Jun; 222(2):296-306. PubMed ID: 10837119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for fusion between cardiac and skeletal muscle cells.
    Reinecke H; Minami E; Poppa V; Murry CE
    Circ Res; 2004 Apr; 94(6):e56-60. PubMed ID: 15001531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and activity of osteoblast-targeted Cre recombinase transgenes in murine skeletal tissues.
    Liu F; Woitge HW; Braut A; Kronenberg MS; Lichtler AC; Mina M; Kream BE
    Int J Dev Biol; 2004 Sep; 48(7):645-53. PubMed ID: 15470637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducible gene inactivation in neurons of the adult mouse forebrain.
    Erdmann G; Schütz G; Berger S
    BMC Neurosci; 2007 Aug; 8():63. PubMed ID: 17683525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VAChT-Cre. Fast and VAChT-Cre.Slow: postnatal expression of Cre recombinase in somatomotor neurons with different onset.
    Misawa H; Nakata K; Toda K; Matsuura J; Oda Y; Inoue H; Tateno M; Takahashi R
    Genesis; 2003 Sep; 37(1):44-50. PubMed ID: 14502577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel technique for temporally regulated cell type-specific Cre expression and recombination in the pituitary gonadotroph.
    Naik K; Pittman I; Wolfe A; Miller RS; Radovick S; Wondisford FE
    J Mol Endocrinol; 2006 Aug; 37(1):63-9. PubMed ID: 16901924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Z/EG, a double reporter mouse line that expresses enhanced green fluorescent protein upon Cre-mediated excision.
    Novak A; Guo C; Yang W; Nagy A; Lobe CG
    Genesis; 2000; 28(3-4):147-55. PubMed ID: 11105057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity and efficiency of Cre-mediated recombination in Emx1-Cre knock-in mice.
    Guo H; Hong S; Jin XL; Chen RS; Avasthi PP; Tu YT; Ivanco TL; Li Y
    Biochem Biophys Res Commun; 2000 Jul; 273(2):661-5. PubMed ID: 10873661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A tamoxifen-inducible chimeric Cre recombinase specifically effective in the fetal and adult mouse liver.
    Tannour-Louet M; Porteu A; Vaulont S; Kahn A; Vasseur-Cognet M
    Hepatology; 2002 May; 35(5):1072-81. PubMed ID: 11981757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel pan-neuronal Cre-transgenic line for conditional ablation of genes in the nervous system.
    Banares S; Zeh K; Krajewska M; Kermer P; Baribault H; Reed JC; Krajewski S
    Genesis; 2005 May; 42(1):6-16. PubMed ID: 15828007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.